CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,844 | -43.0% | 10,000 | 0.0% | 0.00% | – |
Q2 2023 | $12,000 | +2.6% | 10,000 | 0.0% | 0.00% | – |
Q1 2023 | $11,700 | +48.1% | 10,000 | 0.0% | 0.00% | – |
Q4 2022 | $7,900 | -34.2% | 10,000 | 0.0% | 0.00% | – |
Q3 2022 | $12,000 | +33.3% | 10,000 | 0.0% | 0.00% | – |
Q2 2022 | $9,000 | -50.0% | 10,000 | 0.0% | 0.00% | – |
Q1 2022 | $18,000 | +20.0% | 10,000 | 0.0% | 0.00% | – |
Q4 2021 | $15,000 | -25.0% | 10,000 | 0.0% | 0.00% | – |
Q3 2021 | $20,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
Ergoteles LLC | 451,890 | $416,000 | 0.01% |
Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |